companydata.dkBIOSYNTIA ApS: Financial statements 2018
CVR: 34892970
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -2,671,636 and a net result of DKK -9,431,042 compared with DKK -3,210,394 the year before. Equity amounted to DKK 25,167,776. The solvency ratio was 85%. The company had 18 employees in the financial year.
- Gross Profit
- -2,671,636 kr.
- Profit/Loss
- -9,431,042 kr.
- Equity
- 25,167,776 kr.
- Total Assets
- 29,605,307 kr.
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -2.7 mio. | -9.4 mio. | 25.2 mio. | 18 |
| 2017 | - | 2.2 mio. | -3.2 mio. | 4.8 mio. | 14 |
| 2016 | - | 619 t. | -2.8 mio. | 8 mio. | 8 |
| 2015 | - | 1.2 mio. | -1.7 mio. | 3.9 mio. | - |
| 2014 | - | 1.6 mio. | -4 t. | 48 t. | - |
Keep an eye on BIOSYNTIA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
BIOSYNTIA ApS has published its annual report for 2017. Gross profit came to DKK 2,197,797, and the net result was DKK -3,210,394.
As of April 24, 2018, Joško Bobanović has joined the board of directors of BIOSYNTIA ApS.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees. In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity amounted to DKK 32,860,576.